Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD) today announced that Bradley Campbell, President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 8, 2024, at 2:15 p.m. PT.
Related news for (FOLD)
- Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
- Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
- Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
- Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook
- 24/7 Market News Snapshot 17 October, 2024 – Amicus Therapeutics, Inc (NASDAQ:FOLD)